Resveratrol-induced changes of the human adipocyte secretion profile

Journal of Proteome Research

Volumn 11, Issue 9, 2012, Pages 4733-4743

  Rosenow, Anja ^a   Noben, Jean Paul ^b   Jocken, Johan ^a   Kallendrusch, Sonja ^a   Fischer Posovszky, Pamela ^c   Mariman, Edwin C M ^a   Renes, Johan ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b HASSELT UNIVERSITY   (Belgium)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

2 DE LC MS MS; adipokines; human adipocytes; lipolysis; RSV

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN E; GLYCEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESVERATROL; TRIACYLGLYCEROL;

ADIPOCYTE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BIOINFORMATICS; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; LIPOLYSIS; LIQUID CHROMATOGRAPHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE; UPREGULATION;

ADIPOCYTES; ADIPOKINES; CELL LINE; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LIPOLYSIS; PROTEINS; PROTEOME; REPRODUCIBILITY OF RESULTS; STILBENES; TANDEM MASS SPECTROMETRY;

RICE STRIPE VIRUS;

EID: 84866071010     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300539b     Document Type: Article

References (79)

1. Baur, J. A.; Pearson, K. J.; Price, N. L.; Jamieson, H. A.; Lerin, C.; Kalra, A.; Prabhu, V. V.; Allard, J. S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P. J.; Poosala, S.; Becker, K. G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K. W.; Spencer, R. G.; Lakatta, E. G.; Le Couteur, D.; Shaw, R. J.; Navas, P.; Puigserver, P.; Ingram, D. K.; de Cabo, R.; Sinclair, D. A. Resveratrol improves health and survival of mice on a high-calorie diet Nature 2006, 444 (7117) 337-42 (Pubitemid 44764104)
2. Roemer, K.; Mahyar-Roemer, M. The basis for the chemopreventive action of resveratrol Drugs Today 2002, 38 (8) 571-80
3. Baur, J. A. Resveratrol, sirtuins, and the promise of a DR mimetic Mech. Ageing Dev. 2010, 131, 261-9
4. Pearson, K. J.; Baur, J. A.; Lewis, K. N.; Peshkin, L.; Price, N. L.; Labinskyy, N.; Swindell, W. R.; Kamara, D.; Minor, R. K.; Perez, E.; Jamieson, H. A.; Zhang, Y.; Dunn, S. R.; Sharma, K.; Pleshko, N.; Woollett, L. A.; Csiszar, A.; Ikeno, Y.; Le Couteur, D.; Elliott, P. J.; Becker, K. G.; Navas, P.; Ingram, D. K.; Wolf, N. S.; Ungvari, Z.; Sinclair, D. A.; de Cabo, R. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span Cell Metab. 2008, 8 (2) 157-68
5. Timmers, S.; Konings, E.; Bilet, L.; Houtkooper, R. H.; van de Weijer, T.; Goossens, G. H.; Hoeks, J.; van der Krieken, S.; Ryu, D.; Kersten, S.; Moonen-Kornips, E.; Hesselink, M. K.; Kunz, I.; Schrauwen-Hinderling, V. B.; Blaak, E. E.; Auwerx, J.; Schrauwen, P. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans Cell Metab. 2011, 14 (5) 612-22
6. Olholm, J.; Paulsen, S. K.; Cullberg, K. B.; Richelsen, B.; Pedersen, S. B. Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants Int. J. Obes. 2010, 34 (10) 1546-53
7. Howitz, K. T.; Bitterman, K. J.; Cohen, H. Y.; Lamming, D. W.; Lavu, S.; Wood, J. G.; Zipkin, R. E.; Chung, P.; Kisielewski, A.; Zhang, L. L.; Scherer, B.; Sinclair, D. A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 2003, 425 (6954) 191-6 (Pubitemid 37150899)
8. Lin, S. J.; Defossez, P. A.; Guarente, L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae Science 2000, 289 (5487) 2126-8
9. Park, C. E.; Kim, M. J.; Lee, J. H.; Min, B. I.; Bae, H.; Choe, W.; Kim, S. S.; Ha, J. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase Exp. Mol. Med. 2007, 39 (2) 222-9 (Pubitemid 46683408)
10. Park, S. J.; Ahmad, F.; Philp, A.; Baar, K.; Williams, T.; Luo, H.; Ke, H.; Rehmann, H.; Taussig, R.; Brown, A. L.; Kim, M. K.; Beaven, M. A.; Burgin, A. B.; Manganiello, V.; Chung, J. H. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases Cell 2012, 148 (3) 421-33
11. Gregoire, F. M. Adipocyte differentiation: from fibroblast to endocrine cell Exp. Biol. Med. 2001, 226 (11) 997-1002
12. Lehr, S.; Hartwig, S.; Sell, H. Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders Proteomics: Clin. Appl. 2012, 6 (1-2) 91-101
13. Diamanti-Kandarakis, E.; Palioura, E.; Kandarakis, S. A.; Koutsilieris, M. The Impact of Endocrine Disruptors on Endocrine Targets Horm. Metab. Res. 2010, 42 (8) 543-52
14. Rosenow, A.; Arrey, T. N.; Bouwman, F. G.; Noben, J. P.; Wabitsch, M.; Mariman, E. C.; Karas, M.; Renes, J. Identification of novel human adipocyte secreted proteins by using SGBS cells J. Proteome Res. 2010, 9, 5389-401
15. Wabitsch, M.; Brenner, R. E.; Melzner, I.; Braun, M.; Moller, P.; Heinze, E.; Debatin, K. M.; Hauner, H. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation Int. J. Obes. Relat. Metab. Disord. 2001, 25 (1) 8-15 (Pubitemid 32142378)
16. Bouwman, F.; Renes, J.; Mariman, E. A combination of protein profiling and isotopomer analysis using matrix-assisted laser desorption/ionization-time of flight mass spectrometry reveals an active metabolism of the extracellular matrix of 3T3-L1 adipocytes Proteomics 2004, 4 (12) 3855-63 (Pubitemid 39657462)
17. Dumont, D.; Noben, J. P.; Moreels, M.; Vanderlocht, J.; Hellings, N.; Vandenabeele, F.; Lambrichts, I.; Stinissen, P.; Robben, J. Characterization of mature rat oligodendrocytes: a proteomic approach J. Neurochem. 2007, 102 (2) 562-76 (Pubitemid 47000599)
18. Barsnes, H.; Vizcaino, J. A.; Eidhammer, I.; Martens, L. PRIDE Converter: making proteomics data-sharing easy Nat. Biotechnol. 2009, 27 (7) 598-9
19. Vizcaino, J. A.; Cote, R.; Reisinger, F.; Barsnes, H.; Foster, J. M.; Rameseder, J.; Hermjakob, H.; Martens, L. The Proteomics Identifications database: 2010 update Nucleic Acids Res. 2010, 38 (Database issue) D736-42
20. Wang, R.; Fabregat, A.; Rios, D.; Ovelleiro, D.; Foster, J. M.; Cote, R. G.; Griss, J.; Csordas, A.; Perez-Riverol, Y.; Reisinger, F.; Hermjakob, H.; Martens, L.; Vizcaino, J. A. PRIDE Inspector: a tool to visualize and validate MS proteomics data Nat. Biotechnol. 2012, 30 (2) 135-7
21. Lehr, S.; Hartwig, S.; Lamers, D.; Famulla, S.; Muller, S.; Hanisch, F. G.; Cuvelier, C.; Ruige, J.; Eckardt, K.; Ouwens, D. M.; Sell, H.; Eckel, J. Identification and validation of novel adipokines released from primary human adipocytes Mol. Cell. Proteomics 2012, 11 (1) M111 010504
22. Alvarez-Llamas, G.; Szalowska, E.; de Vries, M. P.; Weening, D.; Landman, K.; Hoek, A.; Wolffenbuttel, B. H.; Roelofsen, H.; Vonk, R. J. Characterization of the human visceral adipose tissue secretome Mol. Cell. Proteomics 2007, 6 (4) 589-600 (Pubitemid 46630092)
23. Chen, X.; Cushman, S. W.; Pannell, L. K.; Hess, S. Quantitative proteomic analysis of the secretory proteins from rat adipose cells using a 2D liquid chromatography-MS/MS approach J. Proteome Res. 2005, 4 (2) 570-7 (Pubitemid 40548165)
24. Kim, J.; Choi, Y. S.; Lim, S.; Yea, K.; Yoon, J. H.; Jun, D. J.; Ha, S. H.; Kim, J. W.; Kim, J. H.; Suh, P. G.; Ryu, S. H.; Lee, T. G. Comparative analysis of the secretory proteome of human adipose stromal vascular fraction cells during adipogenesis Proteomics 2010, 10 (3) 394-405
25. Molina, H.; Yang, Y.; Ruch, T.; Kim, J. W.; Mortensen, P.; Otto, T.; Nalli, A.; Tang, Q. Q.; Lane, M. D.; Chaerkady, R.; Pandey, A. Temporal profiling of the adipocyte proteome during differentiation using a five-plex SILAC based strategy J. Proteome Res. 2009, 8 (1) 48-58
26. Zhong, J.; Krawczyk, S. A.; Chaerkady, R.; Huang, H.; Goel, R.; Bader, J. S.; Wong, G. W.; Corkey, B. E.; Pandey, A. Temporal profiling of the secretome during adipogenesis in humans J. Proteome Res. 2010, 9 (10) 5228-38
27. Zvonic, S.; Lefevre, M.; Kilroy, G.; Floyd, Z. E.; DeLany, J. P.; Kheterpal, I.; Gravois, A.; Dow, R.; White, A.; Wu, X.; Gimble, J. M. Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis Mol. Cell. Proteomics 2007, 6 (1) 18-28 (Pubitemid 46152688)
28. Chiellini, C.; Cochet, O.; Negroni, L.; Samson, M.; Poggi, M.; Ailhaud, G.; Alessi, M. C.; Dani, C.; Amri, E. Z. Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation BMC Mol. Biol. 2008, 9, 26
29. Lim, J. M.; Sherling, D.; Teo, C. F.; Hausman, D. B.; Lin, D.; Wells, L. Defining the regulated secreted proteome of rodent adipocytes upon the induction of insulin resistance J. Proteome Res. 2008, 7 (3) 1251-63
30. Roelofsen, H.; Dijkstra, M.; Weening, D.; de Vries, M. P.; Hoek, A.; Vonk, R. J. Comparison of isotope-labeled amino acid incorporation rates (CILAIR) provides a quantitative method to study tissue secretomes Mol. Cell. Proteomics 2009, 8 (2) 316-24
31. Ahn, J.; Lee, H.; Kim, S.; Ha, T. Resveratrol inhibits TNF-alpha-induced changes of adipokines in 3T3-L1 adipocytes Biochem. Biophys. Res. Commun. 2007, 364 (4) 972-7 (Pubitemid 350090002)
32. Rayalam, S.; Yang, J. Y.; Ambati, S.; Della-Fera, M. A.; Baile, C. A. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes Phytother. Res 2008, 22 (10) 1367-71
33. Kang, L.; Heng, W.; Yuan, A.; Baolin, L.; Fang, H. Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: relative to inhibition of inflammatory responses Biochimie 2010, 92 (7) 786-96
34. Yen, G. C.; Chen, Y. C.; Chang, W. T.; Hsu, C. L. Effects of polyphenolic compounds on tumor necrosis factor-alpha (TNF-alpha)-induced changes of adipokines and oxidative stress in 3T3-L1 adipocytes J. Agric. Food Chem. 2011, 59 (2) 546-51
35. Rivera, L.; Moron, R.; Zarzuelo, A.; Galisteo, M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats Biochem. Pharmacol. 2009, 77 (6) 1053-63
36. Derdemezis, C. S.; Kiortsis, D. N.; Tsimihodimos, V.; Petraki, M. P.; Vezyraki, P.; Elisaf, M. S.; Tselepis, A. D. Effect of plant polyphenols on adipokine secretion from human SGBS adipocytes Biochem. Res. Int. 2011, 2011, 285618
37. Fischer-Posovszky, P.; Kukulus, V.; Tews, D.; Unterkircher, T.; Debatin, K. M.; Fulda, S.; Wabitsch, M. Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner Am. J. Clin. Nutr. 2010, 92 (1) 5-15
38. Costa Cdos, S.; Rohden, F.; Hammes, T. O.; Margis, R.; Bortolotto, J. W.; Padoin, A. V.; Mottin, C. C.; Guaragna, R. M. Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPARgamma1-3 mRNA expression in human visceral adipocytes Obes. Surg. 2011, 21 (3) 356-61
39. Ahn, J.; Cho, I.; Kim, S.; Kwon, D.; Ha, T. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet J. Hepatol. 2008, 49 (6) 1019-28
40. Dixon, J. B. The effect of obesity on health outcomes Mol. Cell. Endocrinol. 2010, 316 (2) 104-8
41. Fischer-Posovszky, P.; Newell, F. S.; Wabitsch, M.; Tornqvist, H. E. Human SGBS cells-a unique tool for studies of human fat cell biology Obes. Facts 2008, 1 (4) 184-9
42. Luo, X.; Hutley, L. J.; Webster, J. A.; Kim, Y. H.; Liu, D. F.; Newell, F. S.; Widberg, C. H.; Bachmann, A.; Turner, N.; Schmitz-Peiffer, C.; Prins, J. B.; Yang, G. S.; Whitehead, J. P. Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factors Diabetes 2012, 61 (1) 124-36
43. Schweiger, M.; Schreiber, R.; Haemmerle, G.; Lass, A.; Fledelius, C.; Jacobsen, P.; Tornqvist, H.; Zechner, R.; Zimmermann, R. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism J. Biol. Chem. 2006, 281 (52) 40236-41 (Pubitemid 46041828)
44. Lasa, A.; Schweiger, M.; Kotzbeck, P.; Churruca, I.; Simon, E.; Zechner, R.; Portillo, M. D. Resveratrol regulates lipolysis via adipose triglyceride lipase J. Nutr. Biochem. 2012, 23 (4) 379-84
45. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; Geny, B.; Laakso, M.; Puigserver, P.; Auwerx, J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 2006, 127 (6) 1109-22 (Pubitemid 44894520)
46. Wenzel, E.; Somoza, V. Metabolism and bioavailability of trans-resveratrol Mol. Nutr. Food Res. 2005, 49 (5) 472-81 (Pubitemid 40780394)
47. Yang, N. C.; Lee, C. H.; Song, T. Y. Evaluation of resveratrol oxidation in vitro and the crucial role of bicarbonate ions Biosci. Biotechnol. Biochem. 2010, 74 (1) 63-8
48. Wee, L. M.; Long, L. H.; Whiteman, M.; Halliwell, B. Factors affecting the ascorbate- and phenolic-dependent generation of hydrogen peroxide in Dulbecco's Modified Eagles Medium Free Radical Res. 2003, 37 (10) 1123-30 (Pubitemid 37265335)
49. Hou, Z.; Sang, S.; You, H.; Lee, M. J.; Hong, J.; Chin, K. V.; Yang, C. S. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation- dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells Cancer Res. 2005, 65 (17) 8049-56 (Pubitemid 41297287)
50. Bai, S. W.; Herrera-Abreu, M. T.; Rohn, J. L.; Racine, V.; Tajadura, V.; Suryavanshi, N.; Bechtel, S.; Wiemann, S.; Baum, B.; Ridley, A. J. Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration BMC Biol. 2011, 9, 54
51. Mader, I.; Wabitsch, M.; Debatin, K. M.; Fischer-Posovszky, P.; Fulda, S. Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis FASEB J. 2010, 24 (6) 1997-2009
52. Furukawa, A.; Tada-Oikawa, S.; Kawanishi, S.; Oikawa, S. H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion Cell. Physiol. Biochem. 2007, 20 (1-4) 45-54 (Pubitemid 46956811)
53. Mariman, E. C. An adipobiological model for weight regain after weight Loss Adipobiology 2011, 3
54. Mariman, E. C.; Wang, P. Adipocyte extracellular matrix composition, dynamics and role in obesity Cell. Mol. Life Sci. 2010, 67 (8) 1277-92
55. Lieber, J. G.; Evans, R. M. Disruption of the vimentin intermediate filament system during adipose conversion of 3T3-L1 cells inhibits lipid droplet accumulation J. Cell Sci. 1996, 109 (Pt 13) 3047-58 (Pubitemid 27029274)
56. Hsu, D. K.; Yang, R. Y.; Liu, F. T. Galectins in apoptosis Methods Enzymol. 2006, 417, 256-73 (Pubitemid 44792714)
57. Ungvari, Z.; Labinskyy, N.; Mukhopadhyay, P.; Pinto, J. T.; Bagi, Z.; Ballabh, P.; Zhang, C.; Pacher, P.; Csiszar, A. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells Am. J. Physiol.: Heart Circ. Physiol. 2009, 297 (5) H1876-81
58. Low, F. M.; Hampton, M. B.; Peskin, A. V.; Winterbourn, C. C. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte Blood 2007, 109 (6) 2611-7 (Pubitemid 46425910)
59. Kim, S. Y.; Kim, T. J.; Lee, K. Y. A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway FEBS Lett. 2008, 582 (13) 1913-8
60. Morinaka, A.; Funato, Y.; Uesugi, K.; Miki, H. Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis Oncogene 2011, 30 (40) 4208-18
61. Harman, D. Aging: a theory based on free radical and radiation chemistry J. Gerontol. 1956, 11 (3) 298-300
62. Huang, S.; Lifshitz, L. M.; Jones, C.; Bellve, K. D.; Standley, C.; Fonseca, S.; Corvera, S.; Fogarty, K. E.; Czech, M. P. Insulin stimulates membrane fusion and GLUT4 accumulation in clathrin coats on adipocyte plasma membranes Mol. Cell. Biol. 2007, 27 (9) 3456-69 (Pubitemid 46685220)
63. Kampinga, H. H.; Craig, E. A. The HSP70 chaperone machinery: J proteins as drivers of functional specificity Nat. Rev. Mol. Cell Biol. 2010, 11 (8) 579-92
64. Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discovery 2006, 5 (6) 493-506 (Pubitemid 44136961)
65. Famulla, S.; Lamers, D.; Hartwig, S.; Passlack, W.; Horrighs, A.; Cramer, A.; Lehr, S.; Sell, H.; Eckel, J. Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells Int. J. Obes. 2011, 35 (6) 762-72
66. Mandal, P.; Park, P. H.; McMullen, M. R.; Pratt, B. T.; Nagy, L. E. The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells Hepatology 2010, 51 (4) 1420-9
67. Baitsch, D.; Bock, H. H.; Engel, T.; Telgmann, R.; Muller-Tidow, C.; Varga, G.; Bot, M.; Herz, J.; Robenek, H.; von Eckardstein, A.; Nofer, J. R. Apolipoprotein E induces antiinflammatory phenotype in macrophages Arterioscler., Thromb., Vasc. Biol. 2011, 31 (5) 1160-8
68. Odrowaz-Sypniewska, G. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome Adv. Med. Sci. 2007, 52, 246-50
69. Wang, J. J.; Zhang, S. X.; Mott, R.; Chen, Y.; Knapp, R. R.; Cao, W.; Ma, J. X. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy Am. J. Physiol.: Renal Physiol. 2008, 294 (5) F1166-73
70. Nieuwdorp, M.; Stroes, E. S.; Meijers, J. C.; Buller, H. Hypercoagulability in the metabolic syndrome Curr. Opin. Pharmacol. 2005, 5 (2) 155-9 (Pubitemid 40378746)
71. Tarnus, E.; Wassef, H.; Carmel, J. F.; Rondeau, P.; Roche, M.; Davignon, J.; Bernier, L.; Bourdon, E. Apolipoprotein E limits oxidative stress-induced cell dysfunctions in human adipocytes FEBS Lett. 2009, 583 (12) 2042-8
72. Espiritu, D. J.; Mazzone, T. Oxidative stress regulates adipocyte apolipoprotein e and suppresses its expression in obesity Diabetes 2008, 57 (11) 2992-8
73. Chen, B.; Lam, K. S.; Wang, Y.; Wu, D.; Lam, M. C.; Shen, J.; Wong, L.; Hoo, R. L.; Zhang, J.; Xu, A. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes Biochem. Biophys. Res. Commun. 2006, 341 (2) 549-56 (Pubitemid 43152139)
74. Yu, B.; Cook, C.; Santanam, N. The aporphine alkaloid boldine induces adiponectin expression and regulation in 3T3-L1 cells J. Med. Food 2009, 12 (5) 1074-83
75. Kadowaki, T.; Yamauchi, T.; Kubota, N.; Hara, K.; Ueki, K.; Tobe, K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J. Clin. Invest. 2006, 116 (7) 1784-92 (Pubitemid 44033298)
76. Sharma, A. M.; Chetty, V. T. Obesity, hypertension and insulin resistance Acta Diabetol. 2005, 42 (Suppl 1) S3-8
77. Wang, P.; Smit, E.; Brouwers, M. C.; Goossens, G. H.; van der Kallen, C. J.; van Greevenbroek, M. M.; Mariman, E. C. Plasma pigment epithelium-derived factor is positively associated with obesity in Caucasian subjects, in particular with the visceral fat depot Eur. J. Endocrinol. 2008, 159 (6) 713-8
78. Borg, M. L.; Andrews, Z. B.; Duh, E. J.; Zechner, R.; Meikle, P. J.; Watt, M. J. Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase Diabetes 2011, 60 (5) 1458-66
79. Skurk, T.; Hauner, H. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1 Int. J. Obes. Relat. Metab. Disord. 2004, 28 (11) 1357-64 (Pubitemid 39481839)